Clinical trial
A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis
NCT02749656 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis
- Lead sponsor
- Siriraj Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 1, 2016
- Completion date
- December 31, 2018
- Enrollment
- 105 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
scalp psoriasis